SMITHSON INVESTMENT TRUST PLC
LEI: 52990070BDK2OKX5TH79
Date: 29 July 2024
INTERIM RESULTS
ANNOUNCEMENT
Results for the six months
ended 30 June 2024
The full Interim Report for the six
months ended 30 June 2024 (the "Interim Report") can be found on
the Company's website at www.smithson.co.uk
Performance Highlights
Net
Asset Value
|
At
|
At
|
At
|
|
30 June
2024
|
30 June
2023
|
31
December 2023
|
Net
assets
|
£2,274,421,000
|
£2,622,930,000
|
£2,551,938,000
|
Net
asset value ("NAV") per
|
|
|
|
ordinary share ("share")
|
1,569.5p
|
1,575.4p
|
1,598.0p
|
Share price
|
1,378.0p
|
1,400.0p
|
1,415.0p
|
Share price discount to NAV1
|
12.2%
|
11.1%
|
11.5%
|
|
|
|
For the
period from
|
|
|
|
Company's
listing on
|
|
Six months
ended
|
Six months
ended
|
19 October
2018 to
|
|
30 June
2024
|
30 June
2023
|
30 June
2024
|
|
%
Change2
|
%
Change2
|
%
Change2
|
NAV
total return per share1
|
-1.8%
|
+11.7%
|
+56.9%
|
Share price total return1
|
-2.6%
|
+7.0%
|
+37.8%
|
Comparator index total return3
|
+3.4%
|
+1.9%
|
+52.2%
|
Ongoing charges ratio1
|
0.9%
|
0.9%
|
1.0%
|
Source: Bloomberg.
1 These are Alternative Performance Measures ("APMs").
Definitions of these, together with how these measures have been
calculated, are disclosed on pages 24 and 25 of the Interim Report
where it is made clear how these APMs relate to figures disclosed
and calculated under IFRS.
2 Total returns are stated in GBP sterling.
3 MSCI World SMID Cap Index, £Net Source:
www.msci.com.
Chairman's Statement
Introduction
I am pleased to present this Interim
Report of Smithson Investment Trust plc (the "Company") for the six
months ended 30 June 2024 ("Interim Report").
Performance
The Company's net asset value
("NAV") per share total return for the period was negative 1.8%
compared with the 3.4% positive return from the MSCI World SMID
Index. This is, as the Investment Manager reports in his half year
review, frustrating. The last two and a half years, and
particularly the last 18 months, have been challenging for
those investing in small and mid-cap stocks.
The performance of the MSCI World
Index, which is driven by the performance of a small number of very
large technology stocks, has been very strong, and the divergence
in performance between the MSCI World Index and the MSCI World SMID
Index over the last 18 months is significant. The MSCI SMID Index
has returned 12.8% over that period, whilst the MSCI World Index
has returned 31.6%. These market conditions, and the performance of
the Company's portfolio, are discussed in more detail in the
Investment Manager's review.
There is no doubt that good returns
can be delivered by investing in small and mid-cap stocks. The
Company's objective is to provide shareholders with long term
growth; the Company's annualised NAV per share performance in the
nearly six years since inception to the end of June 2024 was +8.2%
pa, 0.5 percentage points higher than the return from the MSCI
World SMID Index.
Despite the efforts of the Board to
try to reduce the discount to NAV at which the Company's shares
trade though its buyback programme, the share price performance
continues to be disappointing, with the share price loss for the
first half amounting to 2.6% and the annualised return since
inception lagging NAV performance at +5.8%. The buyback programme
is detailed further below.
Discount and Share Buybacks
Since the end of the first quarter
of 2022 the Company's shares have traded at a discount to net asset
value. The problem of discounts is common across the investment
trust sector, and to put the scale of the problem into context, at
the end of June 2024, according to the Association of Investment
Companies' statistics, some 94% of investment trusts were trading
at a discount and the average discount across the industry at 30
June 2024, excluding 3i, was 15%.
The Board has reacted to the
Company's discount by adopting the common practice of buying back
shares and commenced a programme of regular market purchases in
April 2022. In the first half of 2024 the Board spent £206.4m on
buybacks, representing 8.3% of the issued share capital before the
buyback programme began. This brings the total spent on share
buybacks from the start of the programme in 2022 until the end of
the first half of 2024 to £439.7m, equivalent to 18.2% of the
issued share capital at the start of the buyback programme.
Nevertheless, the discount at the end of June 2024 was
12.2%.
As I mentioned above, discounts are
a common problem across the investment trust industry and despite
the Company, in the first half of 2024, ranking second overall in
the investment trust market in terms of amount bought in and third
in terms of percentage of share capital in issue at the start of
the year bought back, the discount still widened.
Whilst the buyback programme has
clearly not addressed the Company's discount, (although the
discount may have been greater if we had not bought back so many
shares), it has nevertheless brought some benefits to shareholders,
taken as a whole. The accretive value of the buybacks in the first
half amounted to an estimated £25.7m, equivalent to 152% of the
Company's operating expenses; since inception of the programme to
the end of the first half of 2024, £50.2m of estimated accretive
benefit to shareholders has been generated. It should also not be
forgotten that as the Investment Manager's fees are based on market
capitalisation rather than NAV, we estimate the discount has been
responsible for their fees being reduced by some £1.1m in the first
half of the year and by £2.2m during 2023.
When I met shareholders earlier this
year, it was clear that they favoured the higher level of buybacks
and the Board intends to continue allocating a substantial amount
of the Company's capital to the buyback programme if discounts
continue to prevail at high levels.
Results and Dividends
The Company's total loss after tax
for the half year was £71m comprising a capital loss of £77m and a
revenue profit of £6m. The income the Company receives from its
investments tends to be higher in the first half of the year than
in the second half, whereas its expenses are more evenly split
between the half years, and, as in previous years, it is expected
that the full year revenue profit will be lower than in the first
half and may even be negative.
In the first half, the Company's
operating cost ratio ("OCR") was 0.86% compared with the OCR for
2023 of 0.88%. The main reason for the improvement is the impact of
the Company's discount on the Investment Manager's fee. We would
expect this to reverse once the Company's discount narrows and the
share price more closely tracks the NAV.
The Company's objective is to focus
on capital growth and its expenses allocation policies are not
designed to facilitate maximisation of revenue reserves and
dividend payments. Consistent with previous interim periods a
dividend is not proposed by the Board.
There is no current intention to
change the Company's approach. It should not be expected that the
Company will pay a significant annual dividend and it is likely
that no interim dividends will be declared. The Board intends to
declare such annual dividends as are necessary to maintain the
Company's UK investment trust status.
AGM
and Shareholder Engagement
The Company held its Annual General
Meeting on 25 April 2024. It was good to see so many shareholders
attend in person and to hear directly from Simon Barnard, our
portfolio manager, and his team. Simon's presentation is available
on the Company's website.
Following investor feedback to the
Board's original decision not to hold a continuation vote at the
AGM, the decision was reversed, and an ordinary resolution in
favour of continuation of the Company was included in the Notice.
The resolution was passed with 90% of the votes cast in favour. The
Board has also resolved that where similar circumstances arise in
future, the Board will automatically put such a vote to
shareholders at the following AGM. This means that if the average
discount in the first half, prevails in the second half, we will
put another continuation vote to shareholders at the 2025
AGM.
Outlook
Our Investment Manager has continued
to refresh the portfolio, adding new names and exiting some
long-held names, and they continue to believe that the portfolio is
well positioned to achieve the objective to deliver long term
growth in value. The Board shares the Investment Manager's optimism
and is pleased that Simon and his team remain focused on the things
they can control and remain resolute in maintaining their
investment approach.
Although the first half performance
has been disappointing, shareholders should not lose sight of the
fact that the Company has nevertheless outperformed its comparator
index since inception. As our Investment Manager says, the headwind
of rising interest rates will not last forever. The Board continues
to have confidence that the Company's Investment Manager can
execute the strategy successfully, and the Board believes that as
the Company offers investors exposure to some of the best companies
available globally in the small and mid-cap sector, the long-term
investor will be well rewarded.
Diana Dyer Bartlett
Chairman
26 July 2024
Investment Manager's Review
Dear Fellow Shareholder,
The performance of Smithson
Investment Trust ("Smithson"), along with comparators, is laid out
below. For the first half of 2024 the NAV of the Company decreased
by 1.8% and the share price declined by 2.6%. Over the same period,
the MSCI World Small and Mid Cap Index ("SMID"), our reference
index, increased by 3.4%. We also provide the performance of UK
bonds and cash for comparison.
|
|
Launch
to 30.06.24
|
|
Total
Return5 01.01.24 to 30.06.24
%
|
Cumulative
%
|
Annualised
%
|
Smithson NAV1
|
-1.8
|
+56.9
|
+8.2
|
Smithson Share Price
|
-2.6
|
+37.8
|
+5.8
|
Small and Midcap
Equities2
|
+3.4
|
+52.2
|
+7.7
|
UK Bonds3
|
-2.2
|
-7.0
|
-1.3
|
Cash4
|
+2.6
|
+10.2
|
+1.7
|
1 Source: Bloomberg, starting NAV 1000.
2 MSCI World SMID Cap Index, £ Net source:
www.msci.com.
3 Bloomberg/Barclays Bond Indices UK Govt 5-10 yr, source:
Bloomberg.
4 Month £ LIBOR Interest Rate source: Bloomberg.
5 Alternative Performance Measure (see pages 24 to 25) of the
Interim Report.
As a colleague recently commented,
our performance so far this year has been "like watching paint
dry", and I couldn't agree more; we are finding it as frustrating
as you are. While we have had a couple of stock specific issues in
the portfolio, which I discuss below, there is no doubt that this
is a tough time in the market for smaller companies. As has
happened in the past, large and 'glamourous' stocks have outperformed strongly this year,
while small and medium sized companies as an asset class have
struggled, and we only need to look at certain individual companies
to get a sense of the scale of this issue.
One of the most glamourous and best
performing large cap companies this year so far has been Nvidia,
boosted by orders for its chips to facilitate the development of
Generative AI. The shares are up 149% in the first half, or to
put it another way, the company has increased in value by $1.8
TRILLION in the last 6 months alone. In comparison, the most
frequently cited US small cap index, the Russell 2000, which
incidentally, similar to our portfolio, has done very little year
to date, has a total market capitalisation of only $3 trillion. It
is therefore not an exaggeration to say that the level of asset
flows currently being attracted to certain US large cap stocks is
potentially sucking the air out of entire asset classes.
This cannot go on forever, and it reminds me of a quote from
veteran small cap manager, Ralph Wanger, who, suffering from
the same issue, said "there is only one stock market, not two, and
the market will soon shed a tier". Although it's worth pointing out
that he said this over half a century ago.
Why is this now happening again? As
you have seen me comment several times before in these reports, the
short term movements of certain 'risk assets', including the small
and mid-cap equity sectors, have been correlated to the movement in
interest rate expectations. This could be due to the faster growing
nature of small caps vs large caps (causing the higher future
profits to be discounted more by higher interest rates), and the
fact that smaller companies tend to be more operationally and
financially geared, although this latter point does not apply to
the majority of Smithson companies. Whatever the reason, interest
rates increasing by over 50 basis points year to date, as measured
by the US 10-year Treasury yield, has provided a headwind to
performance.
We know that this headwind won't
last forever. But what we should also bear in mind, which is
apparent even from the relatively short operating period of
Smithson, is that when small caps do move, they can really move.
For example, from the trough in October 2022, the NAV of the trust
increased by 23% in the following three months and in Q4 last year,
the NAV was up 18% in just a two month period.
You will notice me having referred
specifically to short term performance, because of course these
factors I discussed are only affecting the short term valuations of
the companies we own, while it is the delivery of growth in profits
and free cash flow from our companies which
will drive the long term performance of the trust. On this point we
can report that over the last twelve months, the growth in free
cash flow for our companies has been 14%, demonstrating why we
remain so enthusiastic about the portfolio, while the free cash
flow yield increased to 3%, from 2.3% this time last
year.
Portfolio turnover adjusted for
share buybacks was 20.0% in the half year, a little higher than the
13.1% last year. Annualised costs were unchanged, with an
Ongoing Charges Figure of 0.9% of NAV (including the annualised
Management Fee of 0.9% of market capitalisation). Costs of dealing,
including taxes, amounted to 0.01% of NAV in the period, similar to
that incurred over the same period last year, which meant that the
annualised Total Cost of Investment was 0.93%.
We have been relatively busy in the
first six months of the year due to the large number of
opportunities being offered to us during this period of price
weakness for high quality small cap companies. We added five
exciting new companies to the portfolio and funded these by selling
out of three existing positions, all of which I describe
below.
One new holding is Inficon, a Swiss
producer of instruments for gas analysis, measurement and control
which are used for leak detection and vacuum control in precise
manufacturing processes including semiconductors, flat panel
displays, solar cells and industrial coatings. With all the fervour
around the number of specialist GPUs being ordered to power
generative AI applications, such as those produced by Nvidia, many
will be surprised to hear that there has actually been a downcycle
in the production of ordinary semiconductor chips since 2021. This
is due to the fact that a shortage of chips in 2020 resulting from
supply disruptions led to an overproduction in 2021 to catch up, in
turn leading to inventories building up just as demand for consumer
items such as cars and TVs softened. Inficon's semiconductor
division, accounting for up to half of group revenue, has suffered
somewhat over the last two years but is now receiving increasing
orders which, based on company data, are accelerating every month.
Longer term, the company is well placed to take advantage of
growing markets, not just in semiconductors, but also in renewable
energy, automotive and water purity, as it is positioned as the
number one or two player in every market it serves. The Management
also believe that being a European company selling semiconductor
related equipment into China will continue to give them an
advantage over US based competitors if geopolitical tensions
escalate.
This position was funded by selling
out of Temenos, a Swiss banking software company that had caused us
much frustration over recent months. We believe that the company
will require more investment in the short and medium term to fix a
badly managed transition to a Software as a Service ("SaaS")
business model, which will likely place pressure on margins and
returns.
Reply is an IT consulting company
based in Italy that helps corporates with technology adoption, not
only with advice and 3rd party software integration but also
developing and coding custom software. They are being increasingly
engaged to help integrate AI technology into corporate IT systems,
and so have direct exposure to the long-term growth in AI adoption.
It strikes us that whoever the winners in AI may be, those helping
companies to implement the resulting technology will not be short
of demand. The company is actually a group of small 'pods' of
specialist teams that focus on very specific IT niches and so the
company grows both organically and through acquiring new pods,
which also enables it to remain at the cutting edge of IT
integration. Part of its advantage is that the group has built up
very strong relationships with large multinational companies, over
decades in some cases, that now provide revenue that is recurring
in nature. Its second advantage is that the majority of its
contracts are fixed price, allowing them to generate higher fees
per employee compared to its peers, who bill by the hour. Lower
corporate IT budgets due to the macroeconomic pressures over the
past couple of years have allowed us to acquire a position in the
company at what we believe to be an attractive 4% free cash flow
yield.
We also started a position in
Melexis, a Belgian company which designs and sells advanced
sensors, integrated circuits and systems principally for the
automotive industry, but also for smart buildings, energy
management and robotics. We are attracted to the fact that it
produces very low cost ($0.50 on average) but highly functional
chips and sensors which are growing, in terms of number used per
car, by around 10% a year. The low cost but high functionality not
only enables this continued penetration into cheaper cars and novel
uses, but also protects the company against copycats, as it is
difficult to design and produce them at much lower cost, and that
is assuming a competitor could guarantee the same functionality and
reliability, which is critical for car manufacturers. As
manufacturers have been running down their inventory over the last
year or so, revenue growth has slowed and the share price has
underperformed. This has created an attractive entry point now
that, as suggested by management at its last quarterly earnings
report, customer inventories were
approaching normal levels and the company's free cash flow is
growing once more.
The positions in Reply and Melexis
were funded by selling our holding in Domino's Pizza Enterprises,
the Australian Domino's franchisor. This is a company that had
performed very well until 2021, after which mis-execution in core
markets including Japan and Germany, led to underperformance. While
management have set out a plan to recover sales in these markets,
we believe that given the length of time this turnaround might
involve, our shareholders' capital would be better deployed in
other opportunities.
We also sold out of our position in
IPG Photonics, a US manufacturer of high-powered lasers for
industrial use to fund a new position in HMS Networks. IPG
Photonics has seen increasing competition from Chinese companies,
which produce lasers with less power and reliability, but also at
far lower prices. This has put a degree of pricing pressure on
IPG's lasers over time and is an issue that we had become
increasingly concerned about.
HMS Networks is a Swedish producer
of factory automation products. It sells devices that are
integrated into factory equipment produced by other manufacturers,
which allow that equipment to communicate with any other type of
equipment or network, thus allowing for the automation of factories
through remote diagnostics, monitoring and control, an important
trend which we expect to continue for many years.
Finally, Choice Hotels is a US based
hotel franchisor known for its Quality Inn and Radisson brands,
among several others. It is another high-quality company with a
strong track record of steady growth and profitability, achieving
over 30% operating margins in recent years. Over the past 12 months
however, the shares have been held back as management pursued a
hostile bid for Wyndham Hotels and Resorts, a lower quality US
hotel business of a similar size to Choice Hotels. This bid was
ultimately abandoned by management in March, who at the same time
communicated to shareholders that the funds earmarked for the deal
would instead be spent on share buybacks, an approach we support
given the currently attractive valuation of 5% free cash flow
yield. We took the opportunity to acquire the position soon after
this announcement was made.
To discuss in more detail the fund
performance in the first half, the top five contributors to
performance are shown below.
|
Country
|
Contribution %
|
Ambu
|
Denmark
|
0.8%
|
Fisher & Paykel
Healthcare
|
New
Zealand
|
0.8%
|
Diploma
|
United
Kingdom
|
0.7%
|
Verisk Analytics
|
United
States
|
0.5%
|
Halma
|
United
Kingdom
|
0.4%
|
Source: Northern Trust
Shares in Ambu, the Danish medical
device manufacturer, performed well after the management team
upgraded its guidance for the full year results after the company
achieved strong revenue growth of over 20% in its disposable
endoscopes business during the first six months.
Fisher & Paykel, the medical
device manufacturer based in New Zealand, contributed to
performance after both strong demand for hospital consumables and a
good reception for its new CPAP mask led management to upgrade
profit guidance.
Diploma is a UK based distributor of
industrial products ranging from seals to laboratory equipment.
Over the past few years it has spent an increasing proportion of
its free cash flow on accretive acquisitions and the first six
months of this year saw a continuation of this trend, with the
share price reacting positively to a combination of another deal
and strong underlying growth.
The US insurance data company Verisk
reported strong earnings in May, since which time the share price
has increased over 25%. The company has generally been on a
positive trend since it divested several underperforming divisions
over the last couple of years, leaving shareholders with only the
highly profitable core insurance data business.
Halma, the UK manufacturer and
distributor of safety and environmental products, also reported
better than expected earnings, with the shares up 13% on the day of
the results release.
The largest detractors of
performance are shown below.
|
Country
|
Contribution %
|
Temenos
|
Switzerland
|
-1.3%
|
Domino's Pizza
Enterprises
|
Australia
|
-1.2%
|
Sabre
|
United
States
|
-1.1%
|
Qualys
|
United
States
|
-0.9%
|
Paycom Software
|
United
States
|
-0.6%
|
Source: Northern Trust
The reasons for the underperformance
of both Temenos and Domino's Pizza Enterprises have been discussed
above and unfortunately they were detractors from the fund's
performance in the first half before they were sold.
Sabre, the US provider of software
to the travel industry, is still recovering from the lack of travel
in the pandemic era. Management released cautious guidance in
February, suggesting that corporate travel was improving at a
slower rate than they had hoped, and they no longer expect growth
in this travel segment for the year. Subsequent to this
announcement, corporate travel growth has actually picked up, so
there is potential for Sabre to produce results ahead of the
lowered market expectations, should this continue.
Qualys provides cyber security
software and its order growth has been held back by general
weakness in corporate IT budgets due to macroeconomic uncertainty.
We expect this to be temporary and for orders to recover once
buyers become more optimistic in their outlook.
Paycom Software is a US company
providing human resources software to small and medium sized
companies. It has recently had an issue with increasing customer
churn, as it transpires that the customer service teams were not
doing nearly as good a job as its excellent sales teams. Management
has refocused the organisation on servicing existing clients before
selling more products to them and we are waiting to see if this
begins to resolve the issue. If this doesn't occur within a
satisfactory timeframe, we would be inclined to exit the
position.
The positioning of the fund is
described below, with a breakdown of the portfolio in terms of
sector and geography at the end of the period. The median year of
foundation of the companies in the portfolio at the end of the half
year was 1965.
Sector
|
30 June
2024 (%)
|
30 June
2023 (%)
|
Industrials
|
41%
|
33%
|
Information Technology
|
26%
|
32%
|
Healthcare
|
11%
|
14%
|
Consumer Discretionary
|
9%
|
10%
|
Consumer Staples
|
8%
|
4%
|
Financials
|
3%
|
3%
|
Materials
|
2%
|
-
|
Communication Services
|
-
|
3%
|
Cash
|
-
|
1%
|
Source: Northern Trust
While the Industrials sector now
appears to be significantly larger than the Information Technology
sector, I would highlight that some companies, including Paycom
Software and Verisk Analytics are classed as industrials by GICS,
with Paycom only recently being reclassified to that sector, while
we would still recognise them as Information Technology companies.
I would also indicate that, given our focus on diversification and
risk control, a 40% weighting in a single sector is the most we
would feel comfortable with, and so this weighting is not expected
to move materially higher. The increase in the Industrial sector
weighting over the last 12 months has occurred from the
outperformance of several companies in the sector, in contrast to
the underperformance of certain Information Technology names. The
Information Technology sector weighting also declined due to the
sales of Temenos and IPG Photonics. The Healthcare weighting
decreased after the sale of Masimo last year while that of the
Consumer Staples sector increased after the additions of Oddity and
Clorox. The new position in the Materials sector reflects the
relatively recent acquisition of Croda.
Country of Listing
|
30 June
2024 (%)
|
30 June
2023 (%)
|
USA
|
48%
|
44%
|
UK
|
16%
|
15%
|
Italy
|
9%
|
10%
|
Germany
|
6%
|
6%
|
Switzerland
|
5%
|
7%
|
Sweden
|
5%
|
3%
|
New Zealand
|
4%
|
2%
|
Denmark
|
4%
|
8%
|
Australia
|
2%
|
4%
|
Belgium
|
1%
|
-
|
Cash
|
-
|
1%
|
Source: Northern Trust
Despite the changes to the
portfolio, there has been very little movement in the geographic
exposure of the fund, with the USA remaining the largest weight, as
it is in the global index, and the UK being second largest,
increasing slightly after the outperformance of Diploma and Halma
and with the addition of Croda. The weighting to Denmark more than
halved after Simcorp was acquired by Deutsche Börse and
subsequently left the portfolio.
Source of Revenue
|
30 June
2024 (%)
|
30 June
2023 (%)
|
North America
|
44%
|
39%
|
Europe
|
32%
|
37%
|
Asia Pacific
|
19%
|
18%
|
Eurasia, Middle East,
Africa
|
3%
|
4%
|
Latin America
|
2%
|
2%
|
Source: Fundsmith
In terms of the location where our
companies generate their sales, the changes to the portfolio
outlined above mean that North America has increased as a source of
revenue, while Europe has declined somewhat. All other regions
remain similar to this time last year.
In closing, we recognise that you
have many options when allocating your capital, many of which have
performed better than Smithson in the first half of this year. We
greatly appreciate your continued support, and hope that we are
able to convince you to keep this faith until the small cap sector
returns to vogue. While we may have to remain patient a little
longer while the paint dries, we remain very optimistic that the
picture will be worth it.
Simon Barnard
Fundsmith LLP
Investment Manager
26 July 2024
Investment Portfolio
Investments held as at 30 June 2024
Security
|
Country of
incorporation
|
Fair value
£'000
|
%
of investments
|
Diploma
|
UK
|
117,954
|
5.2
|
Moncler
|
Italy
|
100,347
|
4.4
|
Verisk Analytics
|
USA
|
98,952
|
4.4
|
Geberit
|
Switzerland
|
92,096
|
4.1
|
Rational
|
Germany
|
91,586
|
4.0
|
Fisher & Paykel
Healthcare
|
New
Zealand
|
87,937
|
3.9
|
Equifax
|
USA
|
87,899
|
3.9
|
Verisign
|
USA
|
87,858
|
3.9
|
Fortinet
|
USA
|
83,591
|
3.7
|
Ambu
|
Denmark
|
80,897
|
3.6
|
Top
10 Investments
|
|
929,117
|
41.1
|
Fevertree Drinks
|
UK
|
77,866
|
3.4
|
Exponent
|
USA
|
76,537
|
3.4
|
Recordati
|
Italy
|
74,582
|
3.3
|
Graco
|
USA
|
71,420
|
3.1
|
Cognex
|
USA
|
70,515
|
3.1
|
Addtech
|
Sweden
|
69,644
|
3.1
|
Choice Hotels
|
USA
|
68,983
|
3.0
|
Spirax-Sarco Engineering
|
UK
|
66,637
|
2.9
|
MSCI
|
USA
|
63,468
|
2.8
|
Qualys
|
USA
|
61,811
|
2.7
|
Top
20 Investments
|
|
1,630,580
|
71.9
|
Rollins
|
USA
|
61,671
|
2.7
|
Halma
|
UK
|
61,604
|
2.7
|
Clorox
|
USA
|
61,558
|
2.7
|
Technology One
|
Australia
|
58,320
|
2.6
|
IDEX
|
USA
|
57,666
|
2.5
|
Nemetschek
|
Germany
|
51,082
|
2.2
|
Oddity
|
Israel
|
50,137
|
2.2
|
Croda
|
UK
|
47,494
|
2.1
|
Sabre
|
USA
|
45,240
|
2.0
|
HMS Networks AB
|
Sweden
|
41,369
|
1.8
|
Paycom Software
|
USA
|
36,477
|
1.6
|
Reply Spa
|
Italy
|
23,601
|
1.0
|
Inficon
|
Switzerland
|
22,354
|
1.0
|
Melexis
|
Belgium
|
22,185
|
1.0
|
Total Investments
|
|
2,271,338
|
100.0
|
Investment Objective and Policy
Investment Objective
The Company's investment objective
is to provide shareholders with long term growth in value through
exposure to a diversified portfolio of shares issued by listed or
traded companies.
Investment Policy
The Company's investment policy is
to invest in shares issued by small and mid-sized listed or traded
companies globally with a market capitalisation (at the time of
initial investment) of between £500 million and £15 billion. The
Company's approach is to be a long-term investor in its chosen
shares. It will not adopt short-term trading strategies.
Accordingly, it will pursue its investment policy by investing in
approximately 25 to 40 companies as follows:
(a) the Company can
invest up to 10 per cent. in value of its gross assets (as at the
time of investment) in shares issued by any single body;
(b) not more than 20
per cent. in value of its gross assets (as at the time of
investment) can be in deposits held with a single body. This limit
will apply to all uninvested cash (except cash representing
distributable income or credited to a distribution account that the
depositary holds);
(c) not more than 20
per cent. in value of its gross assets (as at the time of
investment) can consist of shares issued by the same group. When
applying the limit set out in (a) this provision would allow the
Company to invest up to 10 per cent. in the shares of two group
member companies (as at the time of investment);
(d) the Company's
holdings in any combination of shares or deposits issued by a
single body must not exceed 20 per cent. in value of its gross
assets (as at the time of investment);
(e) the Company must
not acquire shares issued by a body corporate and carrying rights
to vote at a general meeting of that body corporate if the Company
has the power to influence significantly the conduct of business of
that body corporate (or would be able to do so after the
acquisition of the shares).
The Company is to be taken to have
power to influence significantly if it exercises or controls the
exercise of 20 per cent. or more of the voting rights of that body
corporate; and
(f)
the Company must not acquire
shares which do not carry a right to vote on any matter at a
general meeting of the body corporate that issued them and
represent more than 10 per cent. of the shares issued by that body
corporate.
The Company may also invest cash
held for working capital purposes and awaiting investment in cash
deposits and money market funds.
For the purposes of the investment
policy, certificates representing certain shares (for example,
depositary interests) will be deemed to be shares.
Hedging policy
The Company will not use portfolio
management techniques such as interest rate hedging and credit
default swaps.
The Company will not use derivatives
for purposes of currency hedging or for any other
purpose.
Borrowing policy
The Company has the power to borrow
using short-term banking facilities to raise funds for short-term
liquidity purposes or for discount management purposes including
the purchase of its own shares, provided that the maximum gearing
represented by such borrowings shall be limited to 15 per cent. of
the net asset value at the time of drawdown of such borrowings. The
Company may not otherwise employ leverage.
Interim Management Report
The Directors are required to
provide an Interim Management Report in accordance with the FCA's
Disclosure Guidance and Transparency Rules. The Directors consider
that the Chairman's Statement and the Investment Manager's Review
on pages 5 to 6 and 7 to 11 of the Interim Report respectively,
provide details of the important events which have occurred during
the period and their impact on the condensed set of financial
statements. The following statements on principal risks and
uncertainties, related party transactions and the Directors'
responsibility statement below, together constitute the Interim
Management Report for the Company for the period from 1 January
2024 to 30 June 2024.
Principal Risks and Uncertainties
The Board considers that the
principal risks and uncertainties faced by the Company can be
summarised as (i) investment objective and policy risk, (ii) market
risks, (iii) outsourcing risks, (iv) key individuals' risk and (v)
regulatory risks. A detailed explanation of risks and uncertainties
can be found on pages 23 to 25 of the Company's most recent Report
and Accounts for the year ended 31 December 2023. The Board
also considers the risks associated with the macroeconomic backdrop
such as uncertainty over inflation, higher interest rates,
possibility of a recession, the continuing wars in Ukraine and the
Middle East. The Board monitors the potential risks to the Company
and its portfolio and receives regular updates and assurance from
the Investment Manager and other key service providers on
operational resilience and portfolio exposure and
impact.
A review of the period and the
outlook can be found in the Chairman's Statement and in the
Investment Manager's Review.
Related Party Transactions
The Company's Investment Manager,
Fundsmith LLP, is considered a related party in accordance with the
Listing Rules. There have been no changes to the nature of the
Company's related party transactions since the Company's most
recent Report and Accounts for the period ended 31 December
2023 were released. Details of the amounts paid to the Company's
Investment Manager and the Directors during the period are detailed
in the notes to the financial statements.
Directors' Responsibility Statement
The Directors confirm to the best of
their knowledge that:
· the condensed set of financial statements contained within the
Interim Report has been prepared in accordance with International
Accounting Standard 34, "Interim Financial Reporting" as required
by DTR 4.2.4R.
· this Interim Management Report includes a fair review of the
information required by Disclosure and Transparency Rule 4.2.7R
(indication of important events during the first six months, their
impact on the condensed set of Financial Statements and a
description of the principal risks and uncertainties for the
remaining six months of the year); and
· the Interim Financial Statements include a fair review of the
information required by Disclosure and Transparency Rule 4.2.8R
(disclosure of related party transactions and changes
therein).
On behalf of the Board of
Directors
Diana Dyer Bartlett
Chairman
26 July 2024
Condensed Statement of Comprehensive Income
(Unaudited)
|
Notes
|
Unaudited
Six months ended
30 June 2024
|
Unaudited
Six months ended
30 June 2023
|
Audited Year
ended
31 December
2023
|
Revenue
£'000
|
Capital
£'000
|
Total
£'000
|
Revenue
£'000
|
Capital
£'000
|
Total
£'000
|
Revenue
£'000
|
Capital
£'000
|
Total
£'000
|
Income from investments held at fair
value through profit or loss
|
4
|
19,422
|
-
|
19,422
|
21,712
|
-
|
21,712
|
31,116
|
-
|
31,116
|
(Losses)/gains on investments held
at fair value through profit or loss
|
3
|
-
|
(76,434)
|
(76,434)
|
-
|
269,112
|
269,112
|
-
|
291,600
|
291,600
|
Foreign exchange losses
|
|
-
|
(546)
|
(546)
|
(136)
|
(227)
|
(363)
|
(136)
|
(656)
|
(792)
|
Investment management
fees
|
|
(9,472)
|
-
|
(9,472)
|
(10,523)
|
-
|
(10,523)
|
(20,280)
|
-
|
(20,280)
|
Other expenses and transaction
costs
|
|
(733)
|
(309)
|
(1,042)
|
(769)
|
(139)
|
(908)
|
(1,532)
|
(650)
|
(2,182)
|
(Loss)/profit before tax
|
|
9,217
|
(77,289)
|
(68,072)
|
10,284
|
268,746
|
279,030
|
9,168
|
290,294
|
299,462
|
Tax
|
|
(3,059)
|
-
|
(3,059)
|
(5,375)
|
-
|
(5,375)
|
(6,144)
|
-
|
(6,144)
|
(Loss)/profit for the period/year
|
5
|
6,158
|
(77,289)
|
(71,131)
|
4,909
|
268,746
|
273,655
|
3,024
|
290,294
|
293,318
|
(Loss)/return per share
(basic and diluted) (p)
|
5
|
4.00
|
(50.20)
|
(46.20)
|
2.91
|
159.09
|
162.00
|
1.82
|
175.02
|
176.84
|
The Company does not have any income
or expenses which are not included in the profit for the
period.
All of the profit and total
comprehensive income for the period is attributable to the owners
of the Company.
The "Total" column of this statement
represents the Company's Income Statement, prepared in accordance
with International Financial Reporting Standards ("IFRS"). The
"Revenue" and "Capital" columns are supplementary to this and are
prepared under guidance published by the Association of Investment
Companies ("AIC").
All items in the above statement
derive from continuing operations.
The accompanying notes below are an
integral part of these financial statements.
Condensed Statement of Financial Position
(Unaudited)
|
|
Unaudited
|
Unaudited
|
Audited
|
|
|
As at
|
As at
|
As at
|
|
|
30 June
|
30 June
|
31 December
|
|
|
2024
|
2023
|
2023
|
|
Notes
|
£'000
|
£'000
|
£'000
|
Non-current assets
|
|
|
|
|
Investments held at fair value
through profit or loss
|
3
|
2,271,338
|
2,608,856
|
2,538,953
|
Current assets
|
|
|
|
|
Trade and other
receivables
|
|
12,303
|
1,011
|
1,851
|
Cash and cash equivalents
|
|
3,814
|
21,057
|
16,579
|
|
|
16,117
|
22,068
|
18,430
|
Total assets
|
|
2,287,455
|
2,630,924
|
2,557,383
|
Current liabilities
|
|
|
|
|
Trade and other payables
|
|
(13,034)
|
(7,994)
|
(5,445)
|
Total assets less current liabilities
|
|
2,274,421
|
2,622,930
|
2,551,938
|
Equity attributable to equity shareholders
|
|
|
|
|
Share capital
|
7
|
1,771
|
1,771
|
1,771
|
Share premium
|
|
1,719,487
|
1,719,487
|
1,719,487
|
Capital reserve
|
|
550,630
|
903,412
|
834,305
|
Revenue reserve
|
|
2,533
|
(1,740)
|
(3,625)
|
Total equity
|
|
2,274,421
|
2,622,930
|
2,551,938
|
Net
asset value per share (p)
|
6
|
1,569.5
|
1,575.4
|
1,598.0
|
The accompanying notes below are an
integral part of these financial statements.
Condensed Statement of Changes in Equity
(Unaudited)
For
the six months ended 30 June 2024 (Unaudited)
|
Share
|
Share
|
Capital
|
Revenue
|
|
|
|
capital
|
premium
|
reserve
|
reserve
|
Total
|
|
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
|
Balance at 1 January 2024
|
1,771
|
1,719,487
|
834,305
|
(3,625)
|
2,551,938
|
|
Ordinary shares bought back and held
in treasury
|
-
|
-
|
(205,333)
|
-
|
(205,333)
|
|
Costs on buybacks
|
-
|
-
|
(1,053)
|
-
|
(1,053)
|
|
(Loss)/profit for the
period
|
-
|
-
|
(77,289)
|
6,158
|
(71,131)
|
|
Balance at 30 June 2024
|
1,771
|
1,719,487
|
550,630
|
2,533
|
2,274,421
|
|
For
the six months ended 30 June 2023 (Unaudited)
|
|
|
Share
|
Share
|
Capital
|
Revenue
|
|
|
capital
|
premium
|
reserve
|
reserve
|
Total
|
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
Balance at 1 January 2023
|
1,771
|
2,219,487
|
203,358
|
(6,649)
|
2,417,967
|
Ordinary shares bought back and held
in treasury
|
-
|
-
|
(68,318)
|
-
|
(68,318)
|
Costs on buybacks
|
-
|
-
|
(374)
|
-
|
(374)
|
Transfer of share
premium#
|
-
|
(500,000)
|
500,000
|
-
|
-
|
Profit for the period
|
-
|
-
|
268,746
|
4,909
|
273,655
|
Balance at 30 June 2023
|
1,771
|
1,719,487
|
903,412
|
(1,740)
|
2,622,930
|
For
the year ended 31 December 2023 (Audited)
|
|
|
|
|
Share
|
Share
|
Capital
|
Revenue
|
|
|
capital
|
premium
|
reserve
|
reserve
|
Total
|
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
Balance at 1 January 2023
|
1,717
|
2,219,487
|
203,358
|
(6,649)
|
2,417,967
|
Ordinary shares bought back and held
in treasury
|
-
|
-
|
(158,506)
|
-
|
(158,506)
|
Costs on buybacks
|
-
|
-
|
(841)
|
-
|
(841)
|
Transfer of share
premium#
|
-
|
(500,000)
|
500,000
|
-
|
-
|
Profit for the period
|
-
|
-
|
290,294
|
3,024
|
293,318
|
Balance at 31 December 2023
|
1,771
|
1,719,487
|
834,305
|
(3,625)
|
2,551,938
|
|
|
|
|
|
|
|
|
| |
# On 28 February 2023, High
Court approval was obtained to reduce the Company's share premium
by £500 million. The capital reduction, resulted in a corresponding
increase in the Company's distributable reserves.
The accompanying notes below are an
integral part of these financial statements.
Condensed Statement of Cash Flows
(Unaudited)
|
|
Unaudited
|
Unaudited
|
|
|
|
Six months
|
Six months
|
Audited
|
|
|
ended
|
ended
|
Year ended
|
|
|
30 June
|
30 June
|
31 December
|
|
|
2024
|
2023
|
2023
|
|
Notes
|
£'000
|
£'000
|
£'000
|
Operating activities
|
|
|
|
|
(Loss)/profit before tax
|
|
(68,072)
|
279,030
|
299,462
|
Adjustments for:
|
|
|
|
|
Losses/(gains) on investments held
at fair value through profit or loss
|
3
|
76,434
|
(269,112)
|
(291,600)
|
Increase in receivables
|
|
(669)
|
(516)
|
(90)
|
(Decrease)/increase in
payables
|
|
(270)
|
176
|
(70)
|
Overseas taxation
|
|
(3,059)
|
(3,564)
|
(4,334)
|
Net
cash generated from operating activities
|
|
4,364
|
6,014
|
3,368
|
Investing activities
|
|
|
|
|
Purchase of investments
|
3
|
(244,667)
|
(176,626)
|
(368,464)
|
Sale of investments
|
3
|
430,545
|
232,983
|
514,316
|
Net
cash generated from investing activities
|
|
185,878
|
56,357
|
145,852
|
Financing activities
|
|
|
|
|
Purchase of shares held in
treasury
|
|
(199,837)
|
(65,531)
|
(156,389)
|
Costs relating to buy
backs
|
|
(3,170)
|
(372)
|
(841)
|
Net
cash used in financing activities
|
|
(203,007)
|
(65,903)
|
(157,230)
|
Net
decrease in cash and cash equivalents
|
|
(12,765)
|
(3,532)
|
(8,010)
|
Cash and cash equivalents at start
of the period/year
|
|
16,579
|
24,589
|
24,589
|
Cash and cash equivalents at end of the
period/year
|
|
3,814
|
21,057
|
16,579
|
Comprised of:
|
|
|
|
|
Cash at bank
|
|
3,814
|
21,057
|
16,579
|
The accompanying notes below are an
integral part of these financial statements.
Notes to the Condensed Financial Statements
(Unaudited)
1.
General information
Smithson Investment Trust plc is a
company incorporated on 14 August 2018 in the United Kingdom under
the Companies Act 2006.
The Condensed Interim Financial
Statements (unaudited) have been prepared in accordance with IAS 34
Interim Financial Reporting and the Disclosure Guidance and
Transparency Rules ("DTRs") of the UK's Listing
Authority.
Principal activity
The principal activity of the
Company is that of an investment company within the meaning of
Section 833 of the Companies Act 2006.
The Company commenced activities on
admission to the London Stock Exchange on 19 October
2018.
Going concern
The Directors have adopted the going
concern basis in preparing the Condensed Interim Financial
Statements (unaudited) for the period ended 30 June 2024. The
following is a summary of the Directors' assessment of the going
concern status of the Company, which included consideration of
macroeconomic conditions such as uncertainty over inflation, higher
interest rates, a possible recession and the continuing wars in
Ukraine and the Middle East.
The Directors have a reasonable
expectation that the Company has adequate resources to continue in
operational existence for at least twelve months from the date of
this report. In reaching this conclusion, the Directors have
considered the liquidity of the Company's portfolio of investments
as well as its cash position, income and expense flows. At the date
of approval of this report, the Company has substantial operating
expenses cover and a suitably liquid portfolio with which to
continue share buybacks.
2. Significant accounting policies
The Company's accounting policies
are set out below:
Accounting convention
The financial statements have been
prepared under the historical cost convention (modified to include
investments at fair value through profit or loss) on a going
concern basis and in accordance with UK adopted international
accounting standards in conformity with the requirements of the
Companies Act 2006 and IFRSs as issued by the International
Accounting Standards Board ("IASB") and with the Statement of
Recommended Practice ("SORP") 'Financial Statements of Investment
Trust Companies and Venture Capital Trusts' issued by the
Association of Investment Companies ("AIC") in November 2014 (and
updated in July 2022). They have also been prepared on the
assumption that approval as an investment trust will continue to be
granted.
The Directors believe that it is
appropriate to continue to adopt the going concern basis for
preparing the financial statements for the reasons stated above.
The Company is a UK listed company with a predominantly UK
shareholder base. The results and the financial position of the
Company are expressed in sterling, which is the functional and
presentational currency of the Company. The accounting policies in
this Interim Report are consistent with those applied in the Annual
Report for the year ended 31 December 2023 and have been disclosed
consistently and in line with Companies Act 2006.
Critical accounting judgements and sources of estimation
uncertainty
The Board confirms that no
significant accounting judgements or estimates have been applied to
the financial statements and therefore there is not a significant
risk of a material adjustment to the carrying amounts of assets and
liabilities.
3.
Investments held at fair value through profit or
loss
|
Unaudited
Six months
ended
30 June
2024
£'000
|
Unaudited
Six months
ended
30 June
2023
£'000
|
Audited
Year ended
31 December
2023
£'000
|
Opening book cost
|
2,232,394
|
2,353,438
|
2,353,438
|
Opening investment holding
gains
|
306,559
|
40,410
|
40,410
|
Opening fair value at start of the
period/year
|
2,538,953
|
2,393,848
|
2,393,848
|
Purchases at cost
|
249,147
|
177,331
|
367,539
|
Sales - proceeds
|
(440,328)
|
(231,435)
|
(514,034)
|
(Losses)/gains on
investments
|
(76,434)
|
269,112
|
291,600
|
Closing fair value at end of the
period/year
|
2,271,338
|
2,608,856
|
2,538,953
|
Closing book cost at end of the
period/year
|
1,999,024
|
2,326,975
|
2,232,394
|
Closing unrealised gain at end of
the period/year
|
272,314
|
281,881
|
306,559
|
Valuation at end of the period/year
|
2,271,338
|
2,608,856
|
2,538,953
|
The Company received £440,328,000
excluding transaction costs from investments sold in the period (30
June 2023: £231,435,000, 31 December 2023: £514,034,000). The book
cost of the investments when they were purchased was £482,687,000
(30 June 2023: £203,933,000, 31 December 2023: £489,233,000). These
investments have been revalued over time until they were sold and
unrealised gains/losses were included in the fair value of the
investments.
All investments are
listed.
4. Dividend income
|
Unaudited
|
Unaudited
|
|
|
Six months
|
Six months
|
Audited
|
|
ended
|
ended
|
Year ended
|
|
30 June
|
30 June
|
31 December
|
|
2024
|
2023
|
2023
|
|
£'000
|
£'000
|
£'000
|
UK dividends
|
3,880
|
4,106
|
7,626
|
Overseas dividends
|
15,245
|
15,785
|
20,843
|
Overseas dividends -
special
|
-
|
1,529
|
1,836
|
Bank interest
|
297
|
292
|
811
|
Total
|
19,422
|
21,712
|
31,116
|
5. (Loss)/return per share
(Loss)/return per ordinary share is
as follows:
|
Unaudited
Six months
ended
30 June
2024
|
Unaudited
Six months
ended
30 June
2023
|
Audited
Year ended
31 December
2023
|
|
Revenue
|
Capital
|
Total
|
Revenue
|
Capital
|
Total
|
Revenue
|
Capital
|
Total
|
(Loss)/return for the period/year
(£'000)
|
6,158
|
(77,289)
|
(71,131)
|
4,909
|
268,746
|
273,655
|
3,024
|
290,294
|
293,318
|
(Loss)/return per ordinary share (p)
|
4.00
|
(50.20)
|
(46.20)
|
2.91
|
159.09
|
162.00
|
1.82
|
175.02
|
176.84
|
Return per share is calculated based
on returns for the period and the weighted average number of
153,957,461 shares in issue (excluding treasury shares) in the six months ended 30 June 2024 (30 June
2023: 168,930,514; 31 December 2023: 165,863,972).
6.
Net asset value per share
|
Unaudited
|
Unaudited
|
Audited
|
|
30 June
|
30 June
|
31 December
|
|
2024
|
2023
|
2023
|
Net asset value
|
£2,274,421,000
|
£2,622,930,000
|
£2,551,938,000
|
Shares in issue
|
144,917,958
|
166,497,958
|
159,692,958
|
Net
asset value per share
|
1,569.5p
|
1,575.4p
|
1,598.0p
|
7.
Share capital
|
Unaudited
30 June 2024
|
|
Ordinary
|
Treasury
|
Total
|
Nominal
|
|
Shares
|
Shares
|
Shares
|
Value
|
Issued, allotted and fully paid (ordinary)
|
Number
|
Number
|
Number
|
£'000
|
Ordinary shares in issue at 1
January
|
159,692,958
|
17,415,000
|
177,107,958
|
1,771
|
Ordinary shares bought back and held
in treasury
|
(14,775,000)
|
14,775,000
|
-
|
-
|
|
144,917,958
|
32,190,000
|
177,107,958
|
1,771
|
|
Unaudited
|
|
30 June
2023
|
|
Ordinary
|
Treasury
|
Total
|
Nominal
|
|
Shares
|
Shares
|
Shares
|
Value
|
Issued, allotted and fully paid (ordinary)
|
Number
|
Number
|
Number
|
£'000
|
Ordinary shares in issue at 1
January
|
171,407,958
|
5,700,000
|
177,107,958
|
1,771
|
Ordinary shares bought back and held
in treasury
|
(4,910,000)
|
4,910,000
|
-
|
-
|
|
166,497,958
|
10,610,000
|
177,107,958
|
1,771
|
|
Audited
|
|
31 December
2023
|
|
Ordinary
|
Treasury
|
Total
|
Nominal
|
|
Shares
|
Shares
|
Shares
|
Value
|
Issued, allotted and fully paid (ordinary)
|
Number
|
Number
|
Number
|
£'000
|
Ordinary shares in issue at 1
January
|
171,407,958
|
5,700,000
|
177,107,958
|
1,771
|
Ordinary shares bought back and held
in treasury
|
(11,715,000)
|
11,715,000
|
-
|
-
|
|
159,692,958
|
17,415,000
|
177,107,958
|
1,771
|
During the six months ended 30 June
2024, the Company issued no ordinary shares (30 June 2023: nil, 31
December 2023: nil).
During the six months ended 30 June
2024, the Company bought back to hold in treasury 14,775,000 shares
(30 June 2023: 4,910,000, 31 December 2023: 11,715,000) at a total
cost of £206,386,000 (30 June 2023: £68,692,000, 31 December 2023:
£159,347,000). At the period end, the Company held 32,190,000 (30
June 2023; 10,610,000, 31 December 2023: 17,415,000) shares in
treasury.
Since 30 June 2024 and up to 24 July
2024, a further 2,457,305
ordinary shares have been bought back to hold in
treasury at a total cost of £34,478,000
8. Related party transactions
Fees payable to the Investment
Manager are shown in the Condensed Statement of Comprehensive
Income. As at 30 June 2024, the fee outstanding to the Investment
Manager was £1,331,000 (30 June 2023: £1,673,000, 31 December 2023:
£1,599,000).
Fees are payable at an annual rate
of £47,250 to the Chair of the Board, £42,000 to the Chair of the
Audit Committee, £36,750 to the Chair of the Management Engagement
Committee and £31,500 to Directors.
The Directors had the following
shareholdings in the Company.
|
As at
|
As at
|
As at
|
|
30 June
|
30 June
|
31 December
|
Director
|
2024
|
2023
|
2023
|
Diana Dyer Bartlett
|
10,419
|
8,886
|
10,419
|
Lord St John of Bletso
|
10,000
|
10,000
|
10,000
|
Jeremy Attard-Manche
|
2,500
|
-
|
1,250
|
Denise Hadgill
|
2,578
|
1,111
|
1,111
|
As at 30 June 2024, Terry Smith and
other partners and key employees of the Investment Manager directly
or indirectly and in aggregate, held 1.91% of the issued share
capital of the Company (30 June 2023: 1.80%, 31 December 2023:
1.70%).
9. Events after the reporting period
There were no post-period events
requiring disclosure other than those included in these Condensed
Interim Financial Statements.
10. Status of this
report
These Condensed Interim Financial
Statements are not the Company's statutory accounts for the
purposes of section 434 of the Companies Act 2006. They are
unaudited. The Interim Report will be made available to the public
at the registered office of the Company. The report will also be
available in electronic format on the Company's website,
http://www.smithson.co.uk.
The financial information for the
year ended 31 December 2023 has been extracted from the statutory
accounts which have been filed with the Registrar of Companies. The
auditors' report on those accounts was not qualified and did not
contain statements under sections 498 (2) or (3) of the Companies
Act 2006.
The Interim Report was approved by
the Board of Directors on 26 July 2024.
Company Secretary and registered office:
Apex Listed
Companies Services (UK) Limited
6th Floor
125 London Wall
London
EC2Y 5AS
For further information please
contact Company Secretary at:
Tel: 0203 327 9720
Email:
smithsoncosecmailbox@apexfs.group